Vetigenics LLC

Devoted to developing antibody therapies that help pets with chronic diseases thrive, not just survive.

Philadelphia, United States · Founded 2019

Employees
1–10
Founded
2019
Business Model
B2B

About

Vetigenics is a pet health biopharma company dedicated to developing antibody therapies for pets with chronic diseases including cancer. Founded in 2017 out of the University of Pennsylvania, the company's proprietary CANIBODY® Platform is a fully canine phage display library containing over 40 billion naturally occurring canine antibodies. Vetigenics runs clinical trials in pet dogs for malignant melanoma, urothelial carcinoma, and other solid tumors, while also advancing human medicine through comparative oncology.

Summary

Vetigenics LLC is a Biotech company based in Philadelphia, United States, founded in 2019.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vetigenics LLC on Indexed.vc
<a href="https://indexed.vc/companies/vetigenics-llc"><img src="https://indexed.vc/api/badge/company/vetigenics-llc" alt="Vetigenics LLC on Indexed.vc" width="260" height="76" /></a>